▶ 調査レポート

薬物検査のグローバル市場(~2027):アッセイキット、消耗品、薬物スクリーニングサービス、製品

• 英文タイトル:Drug Testing Market Research Report by Drug Testing Product, Sample Type, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Drug Testing Market Research Report by Drug Testing Product, Sample Type, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19「薬物検査のグローバル市場(~2027):アッセイキット、消耗品、薬物スクリーニングサービス、製品」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2304L078
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、237ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥732,452 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,472,452 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社の当調査レポートでは、世界の薬物検査市場規模が2021年に177.5億ドル、2022年に198.6億ドルとなり、その後2027年までにCAGR 12.07%で成長して351.9億ドルに達すると予測しています。当書は、薬物検査の世界市場を対象とした調査・分析結果をまとめたものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、薬物検査製品別分析(アッセイキット、消耗品、薬物スクリーニングサービス、製品)、サンプル種類別分析(呼気サンプル、毛髪サンプル、口腔液サンプル、尿サンプル)、エンドユーザー別分析(刑事司法制度&法執行機関、薬物検査研究所、薬物治療センター、病院、個人)、地域別分析(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)、競争状況、企業情報などの内容を掲載しています。また、当書には、Abbott Laboratories、Agilent Technologies, Inc.、Alfa Scientific Designs, Inc.、Bio-Rad Laboratories, Inc.、Clinical Reference Laboratory, Inc.、Cordant Health Solutions、Drägerwerk AG、F. Hoffmann-La Roche AG、Legacy Medical Services, LLC.などの企業情報が含まれています。

・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界の薬物検査市場規模:薬物検査製品別
- アッセイキットの市場規模
- 消耗品の市場規模
- 薬物スクリーニングサービスの市場規模
- 製品の市場規模
・世界の薬物検査市場規模:サンプル種類別
- 呼気サンプルの市場規模
- 毛髪サンプルの市場規模
- 口腔液サンプルの市場規模
- 尿サンプルの市場規模
・世界の薬物検査市場規模:エンドユーザー別
- 刑事司法制度&法執行機関における市場規模
- 薬物検査研究所における市場規模
- 薬物治療センターにおける市場規模
- 病院における市場規模
- 個人における市場規模
・世界の薬物検査市場規模:地域別
- 南北アメリカの薬物検査市場規模
アメリカの薬物検査市場規模
カナダの薬物検査市場規模
ブラジルの薬物検査市場規模
...
- アジア太平洋の薬物検査市場規模
日本の薬物検査市場規模
中国の薬物検査市場規模
インドの薬物検査市場規模
韓国の薬物検査市場規模
台湾の薬物検査市場規模
...
- ヨーロッパ/中東/アフリカの薬物検査市場規模
イギリスの薬物検査市場規模
ドイツの薬物検査市場規模
フランスの薬物検査市場規模
ロシアの薬物検査市場規模
...
- その他地域の薬物検査市場規模
・競争状況
・企業情報

The Global Drug Testing Market size was estimated at USD 17.75 billion in 2021 and expected to reach USD 19.86 billion in 2022, and is projected to grow at a CAGR 12.07% to reach USD 35.19 billion by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Drug Testing to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Drug Testing Product, the market was studied across Assay Kits, Consumables, Drug Screening Services, and Products. The Products is further studied across Analytical Instruments, Calibrators & Controls, Rapid Testing Devices, and Sample Collection Tubes. The Analytical Instruments is further studied across Breathalyzers, Chromatography Instruments, and Immunoassay Analyzers. The Rapid Testing Devices is further studied across Oral Fluid Testing Devices and Urine Testing Devices.

Based on Sample Type, the market was studied across Breath Samples, Hair Samples, Oral Fluid Samples, and Urine Samples.

Based on End User, the market was studied across Criminal Justice Systems & Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Individual Users, Pain Management Centers, Universities, and Workplace.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Drug Testing market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Drug Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Drug Testing Market, including Abbott Laboratories, Agilent Technologies, Inc., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Clinical Reference Laboratory, Inc., Cordant Health Solutions, Drägerwerk AG, F. Hoffmann-La Roche AG, Legacy Medical Services, LLC., Omega Laboratories, Inc., Quest Diagnostics Incorporated, Quidel Corporation, Sciteck Clinical Laboratories, Siemens Healthineers AG, and THERMO FISHER SCIENTIFIC.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Drug Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug Testing Market?
4. What is the competitive strategic window for opportunities in the Global Drug Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Drug Testing Market?
6. What is the market share of the leading vendors in the Global Drug Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Drug Testing Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing drug & alcohol consumption
5.1.1.2. Stringent government regulations for drug & alcohol testing
5.1.1.3. Surge in regulatory approvals and product & service development
5.1.2. Restraints
5.1.2.1. Restriction on the drug testing as it is violation of privacy rights in some countries
5.1.3. Opportunities
5.1.3.1. Development of advanced drug testing solutions
5.1.3.2. Intelligent fingerprint drug testing system
5.1.4. Challenges
5.1.4.1. Technical problem in interpreting screening tests and social issue
5.2. Cumulative Impact of COVID-19

6. Drug Testing Market, by Drug Testing Product
6.1. Introduction
6.2. Assay Kits
6.3. Consumables
6.4. Drug Screening Services
6.5. Products
6.6.1. Analytical Instruments
6.6.2.1. Breathalyzers
6.6.2.2. Chromatography Instruments
6.6.2.3. Immunoassay Analyzers
6.6.2. Calibrators & Controls
6.6.3. Rapid Testing Devices
6.6.4.1. Oral Fluid Testing Devices
6.6.4.2. Urine Testing Devices
6.6.4. Sample Collection Tubes

7. Drug Testing Market, by Sample Type
7.1. Introduction
7.2. Breath Samples
7.3. Hair Samples
7.4. Oral Fluid Samples
7.5. Urine Samples

8. Drug Testing Market, by End User
8.1. Introduction
8.2. Criminal Justice Systems & Law Enforcement Agencies
8.3. Drug Testing Laboratories
8.4. Drug Treatment Centers
8.5. Hospitals
8.6. Individual Users
8.7. Pain Management Centers
8.8. Universities
8.9. Workplace

9. Americas Drug Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Drug Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Drug Testing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Abbott Laboratories
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Agilent Technologies, Inc.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Alfa Scientific Designs, Inc.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Bio-Rad Laboratories, Inc.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Clinical Reference Laboratory, Inc.
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Cordant Health Solutions
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Drägerwerk AG
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. F. Hoffmann-La Roche AG
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Legacy Medical Services, LLC.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Omega Laboratories, Inc.
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Quest Diagnostics Incorporated
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Quidel Corporation
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Sciteck Clinical Laboratories
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Siemens Healthineers AG
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. THERMO FISHER SCIENTIFIC
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing